This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Barbara Tevelev
Senior Scientist, Molecular Discovery, Cell Line Development, Bioprocess Research and Development at Pfizer


Barbara Tevelev is a Senior Scientist in the Cell Line Development group at Pfizer’s Biopharma Research and Development Organization. Barbara’s focus is developing and assessing cell lines for monoclonal antibodies and multi-specifics for Phase I projects. She is also responsible for performing phenotypic and genotypic characterization in support of late stage commercial suitability assessment. Some of Barbara’s most recent accomplishments have been centered around developing a new strategy for LIVCA, addressing regulatory concerns, as well as evaluating and streamlining workflows for development and production of complex modalities.

Agenda Sessions

  • Panel Discussion: Cell Line Development: Considerations for the Future

  • Using Site Specific Integration Expression System to Generate Cell Lines for Multi-specific Modalities